iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF
BTEKETFLSE
£6.46 ▲ +0.35%
12 juin 2026
B
iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF
£6.46 ▲ +0.35%
12 juin 2026
BTEKETFLSE

01 / À propos

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Arberion
Loading market data